UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-03, Vol.21 (2), p.276-284

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic parameters of soybean populations obtained from crosses between grain and food genotypes

Acta scientiarum. Agronomy, 2021-01, Vol.43, p.e46968-e46968

2021

Link zum Volltext

Verfügbarkeit prüfen

Selection indices for agronomic traits in segregating populations of soybean

Ciência agronômica, 2017-01, Vol.48 (1), p.110-117

2017

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Cancer Research and Treatment, 2015, 47(3), , pp.343-361

2015

Link zum Volltext

Verfügbarkeit prüfen

Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis

Oncotarget, 2016-11, Vol.7 (46), p.75482-75491

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of superior genotypes and soybean traits by multivariate analysis and selection index

Ciência agronômica, 2018-07, Vol.49 (3), p.491-500

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhancing Clinical Decision-Making in LATAM through Virtual Genitourinary Tumour Boards

Société internationale d'urologie journal, 2023-11, Vol.4 (6), p.454-457

2023

Link zum Volltext

Verfügbarkeit prüfen

Bayesian approach, traditional method, and mixed models for multienvironment trials of soybean

Pesquisa agropecuaria brasileira, 2018-10, Vol.53 (10), p.1093-1100

2018

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

Cancer Research and Treatment, 2015, 47(4), , pp.549-554

2015

Link zum Volltext

Verfügbarkeit prüfen

East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

Cancer Research and Treatment, 2016, 48(4), , pp.1177-1186

2016

Link zum Volltext

Verfügbarkeit prüfen

Strategies to select soybean segregating populations with the goal of improving agronomic traits

Acta scientiarum. Agronomy, 2018-01, Vol.40 (1), p.39324-e39324

2018

Link zum Volltext

Verfügbarkeit prüfen

Ramucirumab in patients with advanced gastric and gastroesophageal junction cancer: Learnings from East Asian data

Journal of cancer research and practice, 2018-06, Vol.5 (2), p.43-46

2018

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial

Cancer Research and Treatment, 2015, 47(4), , pp.616-629

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer

Gynecologic oncology reports, 2014-12, Vol.10 (C), p.36-37

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Journal of clinical oncology, 2016-09, Vol.34 (27), p.3258-3266

2016

Link zum Volltext

Verfügbarkeit prüfen

Survival without common toxicity criteria grade 3/4 toxicity following second-line treatment with pemetrexed for nonsquamous non-small cell lung cancer in Chinese patients

Chinese medical journal, 2013, Vol.126 (24), p.4624-4628

2013

Link zum Volltext

Verfügbarkeit prüfen

Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

Cancer Research and Treatment, 2016, 48(2), , pp.458-464

2016

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT

Cancer Research and Treatment, 2015, 47(3), , pp.424-435

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies or Advanced Epithelial Ovarian Cancer

Clinical cancer research, 2008-10, Vol.14 (19), p.6310-6316

2008

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.91-100

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of superior soybean lines by assessing genetic parameters and path analysis of grain yield components

African journal of biotechnology, 2017-02, Vol.16 (8), p.328-336

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(498)
Mit Volltextzugriff
(541)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(342)
Life Sciences & Biomedicine
(276)
Humans
(180)
Female
(127)
Male
(113)
Middle Aged
(77)
Adult
(71)
Aged
(65)
Oncology
(58)
Animals
(54)
Physical Sciences
(53)
Treatment Outcome
(52)
Biological And Medical Sciences
(41)
Glycine Max
(34)
Medical Sciences
(34)
Agriculture, Multidisciplinary
(32)
Retrospective Studies
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Physics
(31)
Mice
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Reducing Leakage: Subsidies and Tariff Reform in Water and Sanitation Services in Metropolitan Lima, Peru

Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Genetic parameters of soybean populations obtained from crosses between grain and food genotypes

Selection indices for agronomic traits in segregating populations of soybean

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis

Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer

Identification of superior genotypes and soybean traits by multivariate analysis and selection index

Enhancing Clinical Decision-Making in LATAM through Virtual Genitourinary Tumour Boards

Bayesian approach, traditional method, and mixed models for multienvironment trials of soybean

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

Strategies to select soybean segregating populations with the goal of improving agronomic traits

Ramucirumab in patients with advanced gastric and gastroesophageal junction cancer: Learnings from East Asian data

Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Survival without common toxicity criteria grade 3/4 toxicity following second-line treatment with pemetrexed for nonsquamous non-small cell lung cancer in Chinese patients

Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT

A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies or Advanced Epithelial Ovarian Cancer

A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis

Identification of superior soybean lines by assessing genetic parameters and path analysis of grain yield components

Suchergebnisse filtern